Lymphadenopathy secondary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of lymphadenopathy include sentinel lymph node biopsy and early treatment if metastasis is detected. | Effective measures for the secondary prevention of [[lymphadenopathy]] include sentinel [[lymph node]] [[biopsy]] and early treatment if [[metastasis]] is detected. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Revision as of 16:37, 10 February 2021
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy secondary prevention |
|
Risk calculators and risk factors for Lymphadenopathy secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Effective measures for the secondary prevention of lymphadenopathy include sentinel lymph node biopsy and early treatment if metastasis is detected.
Secondary Prevention
Effective measures for the secondary prevention of lymphadenopathy include:[1]
- Sentinel lymph node biopsy
- Early treatment if metastasis is detected
References
- ↑ Kodama T, Matsuki D, Tada A, Takeda K, Mori S (September 2016). "New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network". Sci Rep. 6: 32506. doi:10.1038/srep32506. PMID 27581921.